NAI-SBU News Archive
2026 News
Dr. Anurag Pruwar warded Seed Funding Through the SUNY Technology Accelerator Fund (TAF)
Anurag Purwar is an Associate Professor in the Department of Mechanical Engineering
in Stony Brook’s College of Engineering and Applied Sciences . He was one of four
SUNY Mission TAF awardees for his research, “MotionGen — An AI Platform for Intelligent Mechanism Design in Robotics”. SUNY TAF funding is awarded through a highly competitive process that weighs several
factors, including the availability of intellectual property protection, marketability,
commercial potential, feasibility and breadth of impact.(Read more from SBU News)
We Crunched the Numbers on Drug Discovery in the U.S. vs. China. The Results Were Alarming
Around the world, nations with robust research and development infrastructure race to create therapeutics that meet the needs of their residents. Simply put, they dictate research priorities based on need.
"U.S. biopharma is now a Ford Mustang racing against the Chinese-built BYD Yangwang U9 supercar".
Article by Michael Kinch, Chief Innovation Office and Kevin Gardner, Vice-President for Research and Innovation at Stony Brook University, published in SAT10. (read more)
2025 News
Dr. Carol Carter Elected 2025 NAI Fellow
Carol A. Carter, SUNY Distinguished Professor in the Department of Microbiology and
Immunology of the Renaissance School of Medicine at Stony Brook University, is elected
as a 2025 Fellow of the National Academy of Inventors (NAI) — the highest professional distinction accorded solely to academic inventors. The
NAI Fellows Program was established to highlight academic inventors who have demonstrated
a prolific spirit of innovation in creating or facilitating outstanding inventions
that have made a tangible impact on quality of life, economic development and the
welfare of society. Election to NAI Fellow status is the highest professional distinction
accorded solely to academic inventors. According to the NAI, the 2025 class hold
more than 5,300 U.S. patents and include recipients of the Nobel Prize, the National
Medals of Science and Technology & Innovation, and members of the National Academies
of Sciences, Engineering, and Medicine, among others. This year’s 169 U.S. Fellows
represent 127 universities, government agencies, and research institutions, across
40 U.S. states. The NAI Fellows program was founded in 2012 and has grown to include
2,253 distinguished researchers and innovators, who hold over 86,000 U.S. patents
and 20,000 licensed technologies. Their innovations have generated an estimated $3.8
trillion in revenue and 1.4 million jobs.
Carter is an innovative scholar of remarkable breadth and depth. She is widely recognized as an early pioneer in HIV research and was recently elected a member of the U.S. National Academy of Sciences. Her work on the isolation and purification of recombinant forms of the viral encoded protease and viral capsid protein was critical for advancing understanding in the field. Her groundbreaking research identified that the interaction between HIV-1 and host protein Tsg101 is essential for budding of viral particles from infected cells, opening a new field of research in virology and cell biology.
Dr. Carter has received numerous prestigious honors for her pioneering work, including the David Derse Memorial Retrovirology Award, the Long Island Innovator of the Year Award, the Suffolk County NY Martin Luther King, Jr Commission Public Service Award, and the Stony Brook University Presidential Award for Promoting Diversity and Academic Excellence. She was designated a Pioneer in Molecular Biology by the Journal of Molecular Biology. Then, she was elected to the National Academy of Sciences in 2024.
“Dr. Carter is not only an inventor of great vision but also an exceptional educator, entrepreneur, and mentor whose work radiates outward into society in profoundly meaningful ways,” said Iwao Ojima, President of the Stony Brook University Chapter of the National Academy of Inventors and SUNY Distinguished Professor (Chemistry), and also says “She is precisely the kind of scholar-practitioner with exceptional achievements and future promise, who elevates the mission of the National Academy of Inventors.”
Carter will be inducted to NAI-Fellow at the NAI 15th annual meeting on June 1-4, 2026, in Los Angeles, California. (Read more from the SBU News)
Breast Cancer Dectection: The Transformative Work of Wei Zhao
Dr. Wei Zao, is a Professor in the Departments of Radiology and Biomedical Engineering
at the Stony Brook Renaissance School of Medicine. She is also Program Leader for the Imaging, Biomarker
Discovery and Engineering Sciences (IBES) Research Program of the Stony Brook Cancer
Center (SBCC). (Read more from SB news)
See photo galery Friday June 6
See photo galery Saturday June 7
NAI-SBU Announces the 2025 Young Academic Inventor's Award Winners:
Drs., Christopher Ashdown, Lauren Maloney, Aaron Sloutski (read more)
Dr. Veronique Gouverneur Receives The Ojima Distinguished Lectureship Award in Chemistry
Dr. Veronique Gouverneur gave a lecture at The Ojima Distinguished Lectureship Award
in Chemistry on April 25 at the Wang Center, SBU (read more)
Drug to Treat Neuropathy Advances in Clinical Trials
A compound originally developed at SBU now in clinical development.
A non-opiod investigational drug with promising pre-clinical results in treating neuropathic pain has passed an important hurdle after the study safety review committee (SRC) reviewed the data from initial volunteers and recommended to progress into the next dose level in a first-in-human clinical trial. The drug, ART26.12, is being developed by Artelo Biosciences, based in Solana Beach, CA. The compound was discovered and initially developed by Drs., Iwao Ojima and Martin Kaczocha. From SBU News January 17, 2025 (read more)
2024 NEWS
Dr. Devinder Mahajan elected 2024 NAI Fellow
Dr. Devinder Mahajan, is a professor in the Department of Material Science and Chemical Engineering. He
is also the director of the Intitute of Gas Innovation and Technology (I-GIT). (Read more)
Dr. Arie Kaufman Wins 2024 Test of Time Award for Supercomputing
Dr. Arie Kaufman, distinguished professor in the Department of Computer Science, has been
honored with the SC24 Test of Time Award (TOTA) for supercomputing for his seminal
2004 paper, “GPU Cluster for High Performance Computing.” (read more)
National Academy of Inventors Stony Brook Receives Chapter of Excellence Award
Wei Zhao (center) receiving the NAI Chapter of Excellence Award from Elizabeth Dougherty,
Eastern Regional Outreach Director, and Paul R. Sanberg, president, National Academy
of Inventors. (Read more)from Stony Brook News July 22, 2024
New Drug to Control Pain Related to Cancer Treatment Originally Developed at Stony Brook Gets FDA Clearance
Six years ago Stony Brook University through the Research Foundation for the State
University of New York licensed a promising technology to Artelo Biosciences that identified Fatty Acid Binding Proteins (FABPs) as drug targets of the body’s
endocannabinoid system for a potentially promising way to treat pain, inflammation
and cancer. Now the first one of these compounds has been cleared by the Food and
Drug Administration (FDA) for human clinical trials. Artelo announced this week that
the FDA’s initial approval of one of the FABP5 (5 indicates a specific protein) selective
compounds called ART26.12 enables the company to initiate its first human phase 1
single ascending dose study of the drug. The company states that ART26.12 will address
a critical need for cancer patients, treating chemotherapy-induced peripheral neuropathy.
Phase 1 clinical trials are expected to be launched internationally during the first
half of 2025. The work on FABPs originated with Iwao Ojima, PhD, SUNY Distinguished Professor in
the Department of Chemistry at Stony Brook University, Martin Kaczocha, PhD, Associate
Professor in the Department of Anesthesiology in the Renaissance School of Medicine
at Stony Brook University, and Dale Deutsch, PhD, Professor Emeritus in the Department
of Biochemistry and Cell Biology at Stony Brook University, a research collaboration
affiliated with the ICB&DD. They identified the action of FABPs as drug targets.
Specifically, FABP5 was identified as the intracellular transporter for the endocannabinoid
anandamide (AEA), a neurotransmitter produced in the brain that binds to cannabinoid
receptors. (Read more)from Stony Brook News July 17, 2024.
Dr. Carol Crater Elected to US National Academy of Sciences
Dr. Carol Carter, a Distinguished Professor in the Departmet of Microbiology and
Immunology at the Stony Brook University Renaissance School of Medicine, has been
elected a member of the U.S. National Academy of Sciences (NAS). Carter is the 18th
Stony Brook University faculty member elected to the NAS, and is only the second elected
member from the Renaissance School of Medicine.
(Read more) from SBU News
Ojima Distinguished Lectureship Award in Chemistry - Dr. Hiroaki Suga, Honoree (2024)
The Institute of Chemical Biology and Drug Discovery (ICB&DD), Department of Chemistry,
College of Arts and Sciences and Office of the Provost hosted the “Distinguished Lectureship
Award in Chemistry”, honoring distinguished lecturer Dr. Hiroaki Suga on April 26,
2024. The event took place in the Charles Wang Center, SBU. (Read more) from SBU news
To view photo albun of this event, click the link below
https://photos.app.goo.gl/C7J6kWsMsBx7tzs58
https://photos.app.goo.gl/RV8sqjuXzJ1Xd2TE6
NAI-SBU Announces the 2024 Young Academic Inventor's Award Winners (read more)
Dr. Wei Zhao Elected 2023 NAI Fellow
Dr. Wei Zhao is a Professor in the Departments of Radiology and Biomedical Engineering
in the Stony Brook University Renaissance School of Medicine. She is also Program
Leader for the Imaging, Biomarker Discovery and Engineering Sciences (IBES) Research
Program of the Stony Brook Cancer Center (SBCC). (read more)
For the past few decades, Dr.
Dr. Craig Lehmann is a registered clinical chemist and a Fellow in the National Academy of Clinical
Biochemistry. He is also Dean of the School of Health Technology and Management at
Stony Brook University. As Dean and Professor, Dr. Lehmann leads Undergraduate and
Graduate Programs for Clinical Laboratory Sciences; Respiratory Care; Physician Assistant;
Cytotechnology; Occupational Therapy; Physical Therapy; Health Sciences and Healthcare
Policy and Management. Under his direction, the School of Health Technology and Management
is now the largest of all of the health professions schools at Stony Brook University.
For the past several years, Dr. Lehmann has participated in national and international
conferences, lecturing on emerging technologies that improve the aging experience.
Dr. Lehmann presented at Capitol Hill in Washington, D.C., where he led President
Bush’s Advisor for Science and Technology in discussions that focused on the benefits
of e-technology and the major disease states suited for application; principally,
diabetes, cardiovascular disease and congestive heart failure. To that end, he invented
a medication management device that assists clients and caregivers managing complex
medication regimens and may help reduce the $100-300 billion spent in the U.S. each
year for medication non-adherence issues. The medication manager is licensed to a
Long Island start-up company. Dr. Lehmann’s research, publications, and presentations
on clinical education span many years. He served for three years on the Editorial
Board for the American Association for Clinical Chemistry’s Strategies and Solutions. He is also a member of the Editorial Board of Clinical Laboratory Sciences since 1987. In addition to authoring more than 65 journal articles, Dr. Lehmann is
the author, editor and/or co-editor of five clinical laboratory science textbooks,
which include the “Saunders Manual of Clinical Laboratory Science, Clinical Laboratory
Instrumentation: Theory, Practice and Costs”, “W.B. Saunders and Clinical Diagnostic
Technology: the Total Testing Process”, a three volume series by the American Association
for Clinical Chemistry. Dr. Lehmann has also contributed nine book chapters and produced
a four-part educational video entitled, "Automation in the Clinical Laboratory" published
by W.B. Saunders. He has presented over 125 presentations, worldwide, on clinical
analysis by computer assisted infrared spectroscopy, clinical laboratory education,
workflow analysis, laboratory economics, e-health, point of care testing and disease
management. Dr. Lehmann has also served as a United States delegate for the American
Society for Clinical Laboratory Sciences at three world congresses in Holland, Sweden,
and Australia. He is the recipient of many awards including the “Outstanding Contributions
in Education Award from the American Association for Clinical Chemistry, and the Stony
Brook University Provost's Award for "Exceptional Service to Undergraduate Education"
at Stony Brook University.
Dr. Serge Luryi is a Distinguished Professor of the SBU department of Electrical and Computer Engineering.
He is also a Fellow of the American Physical Society, and a Fellow of the Optical
Society of America. In 1994, Dr. Luryi joined the faculty of Stony Brook University
where he was appointed as Distinguished Professor, the highest-ranking professorship
in the State University of New York system. From 1994 to 2016 he served as Chair of
Electrical and Computer Engineering. Since 1998, he has been the Founding Director
of the New York State Center for Advanced Technology in Sensor Systems (Sensor CAT).
The Sensor CAT was driven by needs of New York State industries that develop, manufacture,
or employ sensors and supported science-based start-ups, especially those connected
with university research. This support included universal modern prototyping facilities,
assistance by the CAT’s Entrepreneur-in-Residence, and the CAT’s connections with
the New York investment community. The Sensor CAT has developed an “All in One” Electrical
Engineering Educational Kit, including laboratories, which allowed Stony Brook University
to become the first research institution to offer a Bachelor of Science in Electrical
Engineering online degree. Since its inception in 1998 the Senor CAT has received
over $20M in funding from NY State, which enabled Dr. Luryi and his team to develop
splendid research facilities at the Sensor CAT. Most of this activity was based
on the patented inventions of Dr. Luryi and his associates in such diverse sensor-related
fields as DNA sequencing and high-energy radiation detection. A preeminent research
scientist, Dr. Luryi was elected to the Fellow of the IEEE for contributions in the field of heterojunction devices, Fellow of the American Physical Society for theory of electron transport in low-dimensional systems and invention of novel
electron devices, and Fellow of the Optical Society of America for outstanding and pioneering contributions to semiconductor optoelectronics, especially
to the physics and photonic applications of low-dimensional semiconductor structures. In 2006, he received the IEEE Long Island Section's Papoulis Award for Excellence
in Engineering and Technology Education with the citation: "For pioneering contributions to include entrepreneurial skills in engineering education
on Long Island." Dr Luryi served on the Editorial Board of the IEEE Transactions on Electron Devices, first as an Associate Editor and then as Editor. He is also the Founding Director
of the triennial advanced research workshop on Future Trends in Microelectronics. During his tenure, Dr Luryi has published over 250 papers and has been awarded 54
US patents in the areas of high-speed electronic and photonic devices, material science,
sensor systems and electronic packaging. Dr. Luryi’s most impactful invention to
industry and society is the endowment of silicon chips with various capabilities,
e.g. optoelectronics. In his impressive career, Dr. Luryi has been a pioneer in
semiconductor research and its commercial application by translating research discoveries
into new technologies. 
